Literature DB >> 9675322

Cancer inhibition by green tea.

H Fujiki1, M Suganuma, S Okabe, N Sueoka, A Komori, E Sueoka, T Kozu, Y Tada, K Suga, K Imai, K Nakachi.   

Abstract

Green tea is now an acknowledged cancer preventive in Japan. This paper discusses several important features of (-)-epigallocatechin gallate (EGCG), the main constituent of green tea and tea polyphenols. EGCG and other tea polyphenols inhibited growth of human lung cancer cell line, PC-9 cells with G2/M arrest. 3H-EGCG administered by p.o. intubation into mouse stomach revealed that small amounts of 3H-activity were found in various organs where EGCG and green tea extract had previously demonstrated their anticarcinogenic effects, such as skin, stomach, duodenum, colon, liver, lung and pancreas. Cancer onset of patients who had consumed over 10 cups of green tea per day was 8.7 years later among females and 3.0 years later among males, compared with patients who had consumed under three cups per day. The mechanisms of action of EGCG were briefly discussed with regard to inhibition of tumor necrosis factor-alpha (TNF-alpha) release. Copyright 1998 Elsevier Science B. V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675322     DOI: 10.1016/s0027-5107(97)00310-2

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  23 in total

Review 1.  Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

Authors:  Y D Jung; L M Ellis
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

2.  Synthesis of (2R, 3R)-epigallocatechin-3-O-(4-hydroxybenzoate), a novel catechin from Cistus salvifolius, and evaluation of its proteasome inhibitory activities.

Authors:  Kumi Osanai; Congde Huo; Kristin R Landis-Piwowar; Q Ping Dou; Tak Hang Chan
Journal:  Tetrahedron       Date:  2007-08-06       Impact factor: 2.457

3.  Phlorotannins as radical scavengers from the extract of Sargassum ringgoldianum.

Authors:  Masaaki Nakai; Norihiko Kageyama; Koichi Nakahara; Wataru Miki
Journal:  Mar Biotechnol (NY)       Date:  2006-04-13       Impact factor: 3.619

4.  Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.

Authors:  Anna Hsu; Richard S Bruno; Christiane V Löhr; Alan W Taylor; Rodrick H Dashwood; Tammy M Bray; Emily Ho
Journal:  J Nutr Biochem       Date:  2011-05       Impact factor: 6.048

5.  Anti-inflammatory activity of soy and tea in prostate cancer prevention.

Authors:  Anna Hsu; Tammy M Bray; Emily Ho
Journal:  Exp Biol Med (Maywood)       Date:  2010-06

6.  Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice.

Authors:  Yao-Ping Lu; You-Rong Lou; Jian-Guo Xie; Qing-Yun Peng; Jie Liao; Chung S Yang; Mou-Tuan Huang; Allan H Conney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-30       Impact factor: 11.205

7.  Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells.

Authors:  S Harakeh; K Abu-El-Ardat; M Diab-Assaf; A Niedzwiecki; M El-Sabban; M Rath
Journal:  Med Oncol       Date:  2007-08-14       Impact factor: 3.064

Review 8.  Health-promoting effects of green tea.

Authors:  Yasuo Suzuki; Noriyuki Miyoshi; Mamoru Isemura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

9.  Enhancement or Suppression of ACE Inhibitory Activity by a Mixture of Tea and Foods for Specified Health Uses (FOSHU) That Are Marketed as "Support for Normal Blood Pressure".

Authors:  Isao Murakami; Hiroyuki Hosono; Shigeto Suzuki; Junichi Kurihara; Fumio Itagaki; Machiko Watanabe
Journal:  ISRN Pharm       Date:  2011-08-04

10.  EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression.

Authors:  Jian-Wei Gu; Kristina L Makey; Kevan B Tucker; Edmund Chinchar; Xiaowen Mao; Ivy Pei; Emily Y Thomas; Lucio Miele
Journal:  Vasc Cell       Date:  2013-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.